Simple Summary Hepatocellular carcinoma (HCC) is characterized by a broad molecular
and genetic heterogeneity, which makes it a challenging subject in terms of the underlying …

Breast cancer (BC) is one of the most common malignant tumors in women globally, and its
occurrence has surpassed lung cancer and become the biggest threat for women. At …

To overcome chemotherapy resistance, novel strategies sensitizing cancer cells to
chemotherapy are required. Here, we screen the lysyl-oxidase (LOX) family to clarify its …

Background Transarterial embolization (TAE) is the most common treatment for
hepatocellular carcinoma (HCC); however, there remain limited data describing the …

Ferroptosis, a distinct type of regulated cell death, has been reported to be involved in the
tumorigenesis of liver hepatocellular carcinoma (LIHC). However, the precise functions and …

Despite the application of antiviral drugs and improved surveillance tools, the number of
patients diagnosed with hepatocellular carcinoma (HCC) at an advanced stage and with a …

Hepatocellular carcinoma (HCC) is the most common type of primary hepatic cancer and is
among the major causes of mortality due to cancer. Due to the lack of efficient conventional …

Hepatocellular carcinoma (HCC) is an aggressive malignancy. Previous studies have found
that lamin B1 (LMNB1) contributes to the development of human cancers. However, the …

Simple Summary Hepatocellular carcinoma (HCC), an advanced liver cancer, has poor
prognosis and limited treatment options. Tumor Treating Fields (TTFields) therapy is a novel …

Role of immunotherapy in the management of hepatocellular carcinoma: current standards and
future directions Page 1 S152 Current Oncology, Vol. 27, Supp. 3, November 2020 © 2020 …